LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma

Abstract

These findings demonstrate that WEE2-AS1 is a promising biomarker for the diagnosis and prognosis of patients with glioma. An increased understanding of its effects on the regulation of cell growth may lead to the development of clinical applications that improve the prognostic status of patients with glioma.